Harry Vrieling
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Capturing breast cancers' copy-number landscape in routine pathology: Exploiting low-resolution, genome-wide sequencing to identify HRD and beyond.
Journal: British journal of cancer
Published: July 12, 2024
Performance of a RAD51-based functional HRD test on paraffin-embedded breast cancer tissue.
Journal: Breast cancer research and treatment
Published: June 13, 2023
Substantiate a read-across hypothesis by using transcriptome data-A case study on volatile diketones.
Journal: Frontiers in toxicology
Published: January 31, 2023
Divergent Molecular and Cellular Responses to Low and High-Dose Ionizing Radiation.
Journal: Cells
Published: October 20, 2022
RAD51 as a functional biomarker for homologous recombination deficiency in cancer: a promising addition to the HRD toolbox?
Journal: Expert review of molecular diagnostics
Published: December 16, 2021
Low and high doses of ionizing radiation evoke discrete global (phospho)proteome responses.
Journal: DNA repair
Published: October 28, 2021
The RAD51-FFPE Test; Calibration of a Functional Homologous Recombination Deficiency Test on Diagnostic Endometrial and Ovarian Tumor Blocks.
Journal: Cancers
Published: May 05, 2021
Correction: Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: June 25, 2020
The EU-ToxRisk method documentation, data processing and chemical testing pipeline for the regulatory use of new approach methods.
Journal: Archives of toxicology
Published: January 28, 2020
Last Updated: 09/26/2026